These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27018505)

  • 1. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products.
    Ragham PK; Chandrasekhar KB
    J Pharm Biomed Anal; 2016 Jun; 125():122-9. PubMed ID: 27018505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two aerosol-based detectors for the analysis of gabapentin in pharmaceutical formulations by hydrophilic interaction chromatography.
    Jia S; Park JH; Lee J; Kwon SW
    Talanta; 2011 Oct; 85(5):2301-6. PubMed ID: 21962646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
    Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
    J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products.
    Ciavarella AB; Gupta A; Sayeed VA; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2007 Apr; 43(5):1647-53. PubMed ID: 17275240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
    Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.
    Narayana MB; Chandrasekhar KB; Rao BM
    J Chromatogr Sci; 2014 Sep; 52(8):818-25. PubMed ID: 23926121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
    Vijayabaskar S; Mahalingam V; Kalaivani
    J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
    Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
    Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of an HPLC method for determination of gabapentin in dosage forms through derivatization with 1-fluoro-2,4-dinitrobenzene.
    Souri E; Jalalizadeh H; Shafiee A
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1427-30. PubMed ID: 17917283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
    Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
    J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive determination and validation of gabapentin in pharmaceutical preparations by HPLC with 4-fluoro-7-nitrobenzofurazan derivatization and fluorescence detection.
    Ulu ST; Kel E
    J Chromatogr Sci; 2011; 49(6):417-21. PubMed ID: 21682989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a stability-indicating RP-LC method for the separation of a critical pair of impurities and their degradants in zafirlukast.
    Thiyagarajan TK; Abdul Hakeem JA; Baksam V
    J Chromatogr Sci; 2012; 50(10):945-52. PubMed ID: 22689905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a reversed-phase ultra-performance liquid chromatographic method for assay of lacidipine and related substances.
    Mohan A; Patel HB; Saravanan D
    J AOAC Int; 2011; 94(6):1800-6. PubMed ID: 22320087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
    Rao RN; Ramakrishna K; Sravan B; Santhakumar K
    J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.